Clinical Trials
38 trialsTrial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons
National Institutes of Health Clinical Center (CC)
Treatment and Natural History Study of Lymphomatoid Granulomatosis
National Institutes of Health Clinical Center (CC)
EBV-TCL-01
Maisonneuve-Rosemont Hospital
Prevent
AlloVir
A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Dana-Farber Cancer Institute
VANCE
Tessa Therapeutics
Valganciclovir (Valcyte) for Chronic Fatigue Syndrome Patients Who Have Elevated Antibody Titers Against Human Herpes Virus 6 (HHV-6)and Epstein-Barr Virus (EBV)
Stanford University
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
University of Minnesota
Magnesium Supplementation in People With XMEN Syndrome
National Institutes of Health Clinical Center (CC)
Mental Training for CFS Following EBV Infection in Adolescents
University Hospital, Akershus
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
National Institute of Allergy and Infectious Diseases (NIAID)
ACE
Medical College of Wisconsin
Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Chinese University of Hong Kong
CHARMS
AlloVir
Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation
University of Erlangen-Nürnberg Medical School
Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
National Institutes of Health Clinical Center (CC)
SCAEBV
Baylor College of Medicine
EUCLID
Baylor College of Medicine
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
University of Giessen
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
GlaxoSmithKline
ARMS
AlloVir
Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma
Celgene
A Phase Ib Trial of MVA-EBNA1/LMP2 Vaccine in Nasopharyngeal Carcinoma
Cancer Research UK
Bortezomib Plus Rituximab for EBV+ PTLD
Massachusetts General Hospital
CADEN
Baylor College of Medicine
Mono6
University of Minnesota
CHALLAH
Baylor College of Medicine
NPC-CTL
University Health Network, Toronto
ETNA
Baylor College of Medicine
VIRAGE
Baylor College of Medicine
CLANC
Baylor College of Medicine
EPL
Queensland Institute of Medical Research
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
Cancer Research UK
Modified Vaccinia Ankara (MVA) Vaccine Study
Chinese University of Hong Kong
Controlled Trial of Valacyclovir in Infectious Mononucleosis
University of Minnesota
Endobronchial Valve for Emphysema Palliation Trial (VENT)
Emphasys Medical
Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals' EBV (Epstein Barr Virus) Vaccine (268664).
Henogen
Treatment and Suppression of Hairy Leukoplakia in ARC Patients With Oral Acyclovir (ACV)
NIH AIDS Clinical Trials Information Service